Description
2026 PUBLIC LAW PRICING UPDATES.
Base award description: BPA FOR FERRIPROX, REVCOVI
First action · last action
2021-09-09 · 2025-12-12
Transactions
20
First transaction's obligation
$0
Base + all options value (sum of deltas)
$2,250,000
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79720D0214
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 20 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2021-09-09+$0= $0
- Mod P000012021-09-22+$0= $0
- Mod P000022021-12-07+$0= $0
- Mod P000032022-07-13+$0= $0
- Mod P000042022-07-18+$0= $0
- Mod P000052022-11-21+$0= $0
- Mod P000062022-12-02+$0= $0
- Mod P000072023-06-12+$0= $0
- Mod P000082023-07-24+$0= $0
- Mod P000092023-08-01+$0= $0
- Mod P000102023-12-11+$0= $0
- Mod P000112024-04-15+$0= $0
- Mod P000122024-08-12+$0= $0
- Mod P000132024-12-19+$0= $0
- Mod P000142024-12-20+$0= $0
- Mod P000152024-12-20+$0= $0
- Mod P000162025-04-14+$0= $0
- Mod P000172025-07-31+$0= $0
- Mod P000182025-07-31+$0= $0
- Mod P000192025-12-12+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2021-09-09 | +$0 | $0 | BPA FOR FERRIPROX, REVCOVI |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-09-22 | +$0 | $0 | DELETION OF ONE FERRIPROX NDC, INCORPORATE TWO FERRIPROX NDC CHANGES INTO BPA 36E79721A0020. |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-12-07 | +$0 | $0 | 2022 PUBLIC LAW PRICING UPDATES |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-07-13 | +$0 | $0 | DELETION OF TWO FERRIPROX AND ONE REVCOVI NDC, AND INCORPORATE ONE REVCOVI NDC CHANGE INTO BPA 36E79721A0020. |
| Mod P00004· EXERCISE AN OPTION | 2022-07-18 | +$0 | $0 | EXERCISE OPTION YEAR 1 ON BPA 36E79721A0020 |
| Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-11-21 | +$0 | $0 | ADDITION OF TWO BRONCHITOL NDCS (10122-0212-56 AND 10122-0212-04) |
| Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-12-02 | +$0 | $0 | 2023 PUBLIC LAW PRICING UPDATES |
| Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-06-12 | +$0 | $0 | LAMZEDE AND FERRIPROX PRODUCT ADDITIONS |
| Mod P00008· EXERCISE AN OPTION | 2023-07-24 | +$0 | $0 | MODIFICATION TO EXERCISE OPTION YEAR 2 ON BPA 36E79721A0020. THE PERIOD OF PERFORMANCE IS 09/10/2023 - 09/09/2… |
| Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-08-01 | +$0 | $0 | ADDITION OF ELFABRICO (3 LINE ITEMS) TO BPA. |
| Mod P00010· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-12-11 | +$0 | $0 | 2024 PUBLIC LAW PRICING UPDATES |
| Mod P00011· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-04-15 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE THE PRODUCT ADDITIONS OF 4 JUXTAPID NDCS AND 1 MYALEPT NDC TO BPA 3… |
| Mod P00012· EXERCISE AN OPTION | 2024-08-12 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO EXERCISE OPTION YEAR 3 ON BPA 36E79721A0020. |
| Mod P00013· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-12-19 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE A PRICE INCREASE TO 3 NDCS ON BPA 36E79721A0020. |
| Mod P00014· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-12-20 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO DELETE 2 BRONCHITOL NDCS FROM BPA 36E79721A0020. |
| Mod P00015· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-12-20 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE 2025 PUBLIC LAW PRICING UPDATES INTO BPA 36E79721A0020. |
| Mod P00016· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-04-14 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE THE PRODUCT ADDITIONS OF 4 JUXTAPID NDCS AND 1 ELFABRIO NDC TO BPA… |
| Mod P00017· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-07-31 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE THE PRODUCT ADDITIONS OF 4 JUXTAPID NDCS AND 1 ELFABRIO NDC TO BPA… |
| Mod P00018· EXERCISE AN OPTION | 2025-07-31 | +$0 | $0 | THIS MODIFICATION IS ISSUED TO EXERCISE OPTION YEAR 4 ON BPA 36E79721A0020. |
| Mod P00019· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-12-12 | +$0 | $0 | 2026 PUBLIC LAW PRICING UPDATES. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI M3FAV5PM8B15)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36E79726A0025 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C24522N0311 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $13,551 | FY2022 |
| 36C25821N0374 | 258-NETWORK CNTRCT OFF 22G (36C258) · 6505 · DRUGS AND BIOLOGICALS | $75,951 | FY2021 |
| 36C24521F0516 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $31,646 | FY2021 |
| 36C24521F0489 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $18,988 | FY2021 |
| 36C24521F0387 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $12,658 | FY2021 |
Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36E79726A0024 | NEUROTECH PHARMACEUTICALS, INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0023 | TAKEDA PHARMACEUTICALS AMERICA, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726D0041 | GOLDEN STATE MEDICAL SUPPLY, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0022 | AURINIA PHARMA US INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726D0042 | GOLDEN STATE MEDICAL SUPPLY, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79721A0020_3600 · retrieved 2026-09-26.